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ABSTRACT: Joint injury is the predominant risk factor for post-traumatic osteoarthritis development (PTOA). Several non-invasive
mouse models mimicking human PTOA investigate molecular mechanisms of disease development; none have characterized the
inflammatory response to this acute traumatic injury. Our aim was to characterize the early inflammatory phase and later degenerative
component in our in vivo non-invasive murine model of PTOA induced by anterior cruciate ligament (ACL) rupture. Right knees of 12-
week-old C57Bl6 mice were placed in flexion at a 30˚ offset position and subjected to a single compressive load (12N, 1.4 mm/s) to induce
ACL rupture with no obvious damage to surrounding tissues. Tissue was harvested 4 h post-injury and on days 3, 14, and 21;
contralateral left knees served as controls. Histological, immunohistochemical, and gene analyzes were performed to evaluate
inflammatory and degenerative changes. Immunohistochemistry revealed time-dependent expression of mature (F4/80 positive) and
inflammatory (CD11b positive) macrophage populations within the sub-synovial infiltrate, developing osteophytes, and inflammation
surrounding the ACL in response to injury. Up-regulation of genes encoding acute pro-inflammatory markers, inducible nitric oxide
synthase, interleukin-6 and interleukin-17, and the matrix degrading enzymes, ADAMTS-4 and MMP3 was detected in femoral cartilage,
concomitant with extensive cartilage damage and bone remodelling over 21-days post-injury. Our non-invasive model describes
pathologically distinct phases of the disease, increasing our understanding of inflammatory episodes, the tissues/cells producing
inflammatory mediators and the early molecular changes in the joint, thereby defining the early phenotype of PTOA. This knowledge will
guide appropriate interventions to delay or arrest disease progression following joint injury. ß 2018 The Authors. Journal of Orthopaedic
Research1 Published by WileyPeriodicals, Inc. on behalf of the Orthopaedic Research Society. J Orthop Res 9999:1–10, 2018.
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Unlike primary/idiopathic osteoarthritis (OA), the pre-
dominant risk factor for development of secondary,
often referred to as post-traumatic osteoarthritis
(PTOA) is joint injury. Approximately 12% of all diag-
nosed OA incidents likely arise from a previous joint
trauma,1 with a major joint injury resulting in approxi-
mately 25% of OA cases in susceptible joints, for
example, knee, ankle,2 and >50% of patients with an
anterior cruciate ligament (ACL) injury showing radio-
graphic evidence of OA 10–12 years post-injury.3,4
Various surgical models of PTOA e.g. destabiliza-
tion of the medial meniscus (DMM), meniscal transec-
tion (MNX), are unsuitable for detecting early changes
at the time of injury due to acute inflammatory
responses resulting from the surgery itself. Several
non-invasive mouse models mimicking human PTOA
have been established to investigate molecular mecha-
nisms that underpin disease development and test
interventions immediately post-injury. These models
are reliant on application of a defined, externally
controlled mechanical insult/injury predisposing the
joint to degeneration akin to that observed in the
human disease.5–7 Non-invasive mouse PTOA models
initiate joint degeneration, although the method of
mechanical induction varies between each, ranging
from the very earliest model of intra-articular fracture
of the proximal tibia,8 a single compressive load that
applies an acute injurious impact to the knee,9,10 to
cyclic tibial compression of the lower leg.11–14 As these
PTOA models apply different magnitudes and frequen-
cies of load to the limb, and elicit subtle variances in
severity of joint pathology induced, Blaker et al.
proposed a classification system based on an “idealised
force-displacement curve” with three categories re-
ferred to as Types I–III PTOA.5 Type I PTOA models
reflect immediate structural damage and/or joint
instability induced by mechanical overloading to insti-
gate ACL rupture or intra-articular fracture. Type II
PTOA models involve application of a significant
mechanical insult, but unlike those of Type I PTOA,
do not result in major structural defects to the joint
tissues nor observable joint instability, for example,
single or multiple sessions of joint loading, single sub-
failure joint loading, or loads that induce only partial
soft tissue tears. In contrast, Type III PTOA is
characterized by low-level joint loading which affects
tissue homeostasis but does not impact on joint
stability.
Type I PTOA models of ACL rupture, typically
induced by a single episode of compressive load to the
This is an open access article under the terms of the Creative
Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is
properly cited.
Conflict of interest: There are no conflicts of interest to disclose
for any of the authors.
Grant sponsor: Arthritis Research UK; Grant numbers: 18461,
510390.
Correspondence to: S.J. Gilbert (T: þ44 (0) 29 20874287/þ44 (0)
29 20875171; E-mail: gilbertsj1@cardiff.ac.uk)
# 2018 The Authors. Journal of Orthopaedic Research1 Published by
WileyPeriodicals, Inc. on behalf of the Orthopaedic Research Society.
JOURNAL OF ORTHOPAEDIC RESEARCH1 MONTH 2018 1
lower limb (12N, 1 mm/s), are characterized by exten-
sive loss of trabecular bone, osteophyte formation and
loss of articular cartilage proteoglycans, concomitant
with fissuring and chondrocyte apoptosis in the super-
ficial zone over an 8-week period post-induction of
injury.9 Increasing the loading rate from 1 mm/s in
this model, which induces an avulsion fracture,9 to
500 mm/s which results in a mid-substance tear, also
leads to substantial joint degeneration and an OA
phenotype.15 Alternatively, multiple cycles of tibial
compressive load have also been used to rupture the
ACL and damage the articular surface resulting in
PTOA with similarities to human disease.14 Type I
PTOA, caused by ACL rupture, generates a significant
inflammatory response; it is thought that PTOA
progression is correlated with the inflammatory profile
as opposed to the sole contribution of one mediator.16
Following mechanical insult, inflammatory mecha-
nisms are hypothesized to instigate development and
progression of joint degeneration including cellular
infiltration, production of cytokines and chemokines,
release/activation of proteolytic enzymes, chondrocyte
apoptosis, subchondral bone remodeling including os-
teophyte production, synovial fibrosis and activation of
other pathways that mediate tissue catabolism.17,18
Some of these biological effects instigated at the time
of trauma, can propagate a sustained response, weeks
to months post-injury and are thought to contribute to
PTOA development.19
Surprisingly, there is limited detail on the inflam-
matory response to acute traumatic injury, with
reporting of the presence of synovitis only (type II
PTOA model:13 Type I PTOA model:14). Furthermore,
the inflammatory response in PTOA models has not
been characterized from the immediate early events
through to late stage disease. An advantage of non-
invasive mechanical injury models is that they allow
characterization of very early events that directly arise
from the trauma itself, on a scale of hours to days, as
well as the extensive joint degeneration observed over
time. Since these early inflammatory events may drive
end stage joint degeneration, such models provide an
opportunity to define the “window of therapeutic
opportunity” and identify targets to delay or arrest the
development of PTOA.
The aim of this study was to characterize the
inflammatory and degenerative phases as well as the
later degenerative component in our in vivo murine
model of type I PTOA, where a single compressive load
ruptures the ACL. Definition of the inflammatory
episodes, the tissues/cell types producing inflammatory
mediators and the early molecular changes in the joint
in the early phenotype of PTOA will guide appropriate
interventions to delay or arrest disease progression
following joint injury.
METHODS
All chemicals were from Sigma unless otherwise stated and
were of analytical grade or above. Primary antibodies: Rat
monoclonal to F4/80 (clone Cl:A3-1; AbD Serotec1, Biorad,
Kidlington, UK), rabbit monoclonal to Cd11b (clone
EPR1344; Abcam, Cambridge, UK), rabbit polyclonal to IL-6
(Novusbio Biotechne, Abingdon, UK), Rabbit polyclonal to
IL-17A (Peprotech, London, UK).
Animals
Procedures were performed in compliance with the Animals
(Scientific Procedures) Act 1986 [Home Office licence 30/2959]
according to Home Office and ARRIVE guidelines.20 Twelve-
week old male C57Bl6 mice (25 g, Charles River, UK),
randomly assigned to either experimental or control groups,
were randomly allocated to MB1 cages (960 cm2) in groups of 5
(12 h light–dark cycles, ad libitum food and water). Loading
was performed in the morning. All mice received Buprenor-
phine (0.05 mg/kg) subcutaneously at the start of the experi-
ment, moved freely throughout the experiment and were
monitored for welfare, knee swelling (digital callipers) and
lameness until the end of the experiment. Animal numbers for
each measurement are shown (Suppl. Table S1).
Induction of PTOA
Mice were anaesthetized with isoflurane and custom built
cups21 used to hold the right ankle and knee in flexion with a
30 degree offset prior to the application of a 0.5N pre-load
(ElectroForce1 3200, TA Instruments, Elstree, UK). A single
12N load at a velocity of 1.4 mm/s was then applied resulting
in ACL rupture. These parameters were chosen based upon
prior experiments showing that 12N was a threshold force in
these mice where a mid-substance tear of the ligament would
occur immediately on application of one load cycle at 1.4 mm/
s. ACL rupture was identified through the waveform as a
continued increase in displacement following release of the
applied compressive force with an audible “popping” sound.
To determine whether contralateral knees could serve as
unloaded controls, they were compared with the right and
left knees of na€ve mice which were not subjected to
anaesthetic or load.22 Mice were culled by cervical dislocation
at multiple time points to assess for the presence of an
inflammatory response and joint degeneration.
Specimen Preparation
For histology and immunohistochemistry, hind limbs, at an
orientation of 90 degrees, were immediately fixed post-mortem
in formalin (2 days, 10% neutral buffered formalin), decal-
cified for 2 weeks (4˚C, 10% EDTA, Fisher Scientific, Lough-
borough, UK), and either embedded frontally in paraffin
blocks for coronal sectioning parallel to the tibia, or embedded
side on for sagittal sectioning. Serial sections (5 mm) obtained
at 100 mm intervals through the joint, were dewaxed and
rehydrated prior to staining with Haematoxylin and Eosin,
Toluidine Blue or processing for immunohistochemistry. For
x-ray analysis, knee joints were stored in 70% ethanol
following formalin fixation. Histology on sagittal sections and
x-ray analysis (KODAK In-Vivo Imaging System FX Pro
AMV, Lincoln, UK)23) confirmed rupture with no obvious
damage to the synovium, menisci or other joint tissues (Suppl.
Fig. S1) as previously reported for other non-invasive mouse
models that recapitulate isolated ACL ruptures.9,24
Histological Scoring
The medial femoral condyle (MFC), medial tibial plateau
(MTP), lateral femoral condyle (LFC), and lateral tibial
plateau (LTP) from 2 to 4 coronal sections (either side of the
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centre of the joint, approximately 200 mm apart) were scored
for sub-synovial inflammation and degenerative changes by
two or four independent observers, respectively, blinded to
treatment. For each mouse, a single score representing the
mean value from all observers and sections was used for
statistical comparison. The Osteoarthritis Research Society
International (OARSI) score (Glasson et al.25; Suppl.
Table S2) was used with Toluidine Blue stained sections (0–6
for osteoarthritic changes, 0–3 for subchondral bone changes,
and 0–5 for proteoglycan depletion giving a total score out of
14 for each quadrant). In addition, the presence (þ1) or
absence (0) of osteophytes within the joint was noted.
Haematoxylin and Eosin sections were scored for the pres-
ence of sub-synovial inflammation (Nowell et al.26; Suppl.
Table S2).
Immunohistochemistry
Consecutive coronal sections were deparaffinised and rehy-
drated prior to antigen retrieval (1 mg/ml trypsin for 1 h at
37˚C). Each subsequent step was performed at room temper-
ature unless stated otherwise and between each incubation
step, sections were washed 3 5 min in 0.01 M phosphate
buffered saline (PBS, pH7.4) containing 0.1% (v/v) Tween120
(wash buffer). All antibodies were diluted in wash buffer (F4/
80 1:250, Cd11b 1:100, IL-6 1:500, and IL-17A 1:100).
Endogenous peroxidase activity was blocked with 0.3% (v/v)
hydrogen peroxide for 30 min. Sections were subsequently
treated with 10% normal goat serum for 1 h prior to
overnight incubation (4˚C) with primary antibody, rabbit or
rat IgGs or PBS. Sections were subsequently incubated for
30 min with biotinylated anti-rabbit or anti-rat secondary
antibodies, developed with nickel enhanced diaminobenzi-
dine (DAB) (Vectastain1 Elite ABC kit, DAB, Vector Labora-
tories, Peterborough, UK) and finally dehydrated, cleared in
xylene and mounted. Slides were viewed on a Leica DMRB
microscope. IgG and PBS controls were negative (Suppl.
Fig. S2).
Quantitative RT-PCR Analysis of Gene Expression
Four hours after ACL rupture, mice were culled and knee joints
immediately dissected to expose the femoral condyle cartilage.
Using forceps, pressure was applied to the top of the femur to
“pop” the cartilage from underlying subchondral bone at the
tidemark. Cartilage was pooled from injured (n¼ 9) or unin-
jured (n¼ 9) contra-lateral knees and immediately snap frozen
in liquid nitrogen prior to RNA extraction using TRIzol1
reagent according to manufacturer’s protocol (ThermoFisher
Scientific). Total RNA was purified using a mirVanaTM miR
Isolation Kit followed by DNAse treatment (Ambion, Fisher
Scientific, Loughborough, UK) following the manufacturer’s
protocol and assessed using a spectrophotometer (Nanodrop
1000, ThermoFisher Scientific, Stockport, UK) and 2100 Bio-
analyzer (Agilent Technologies, UK) with A260/280 values
between 1.8–2.0 and RIN scores >8. Complementary DNA
(cDNA, 20 ml total volume) was generated from 300 ng total
RNA using SuperScript1 III reverse transcriptase (Invitrogen
TM, Fisher Scientific) and 0.5 mg random primers (Promega,
Southampton, UK) according to manufacturer’s instructions,
and 1 ml cDNA utilized in each qPCR assay. Quantitative
polymerase chain reaction (qPCR) was performed using SYBR
green detection (Brilliant III Ultra-Fast SYBR1 QPCR mix,
Agilent Technologies) using intron-spanning primers for genes
of interest (Suppl. Table S327), on a QPCR machine
(MxPro3000, Agilent Technologies). All reactions were carried
out at an annealing temperature of 60˚C unless specified
otherwise (Suppl. Table S3) cycling conditions were: 95˚C-3 min
(1 cycle), 95˚C-15 s followed by 60˚C-30 s (40 cycles), 95˚C-1 min
followed by 60˚C-30 s followed by 95˚C-30 s (1 cycle). Primers
(MWG-Biotech AG, Germany), were used at a final concentra-
tion of 200 nM and validated using cDNA standard curves with
all primer efficiencies between 90 and 110%.28 Data were
normalized to 18s and b-actin which were identified from 8
reference genes using RefFinder (http://150.216.56.64/
referencegene.php) as maintaining stable expression under
these experimental conditions.27 Fold-change in expression of
genes of interest was calculated using the 2  DDCT method,29
after normalization to the reference genes and presented
relative to the uninjured contra-lateral limb.
Data Analysis
Data is presented as mean standard error mean (SEM). Data
were tested for normality and equal variances and transformed
if necessary prior to testing by general linear model analysis of
variance (GLM ANOVA) and Tukey’s post hoc test (Minitab
16). Differences were considered significant at p 0.05.
RESULTS
Sub-Synovial Inflammation Results From ACL Injury
Knee swelling following ACL rupture peaked at day-1
and slowly receded over the 21-days (Fig. 1A). Cellular
infiltrate in the sub-synovial lining was evident over
the 21-days (Fig. 1B) and the extent of sub-synovial
inflammation quantified26 (Fig. 1C). By day-3 there
was a significant increase in inflammation score in the
injured legs compared with the uninjured legs
(3.750.23 mm vs. 0.1 0.06 mm; p<0.001). The level
of inflammation peaked in injured knees at day-14
(6.970.36 mm vs. 0.99 0.33 mm; p< 0.001, p<0.001
vs day-3 injured legs) and remained high at day-21
(6.570.33 mm vs 0.430.22 mm; p< 0.001 vs unin-
jured left leg, p< 0.001 vs day-3 injured legs). There
was no statistically significant change in the level of
inflammation in the uninjured legs at any time point.
Mature and Inflammatory Macrophages Increase
Following ACL Injury
Cells positive for F4/80 and CD11b as markers of
mature and inflammatory macrophages respectively,
were detected by immunohistochemistry (Fig. 2).
Three days after ACL rupture cells expressed low or
no F4/80 (Fig. 2A), but 14 days after injury the
abundance of F4/80þ cells increased within the infil-
trate (Fig. 2C, black arrows). In addition, at day-21,
cells within the developing osteophytes expressed F4/80
(Fig. 2E) although many cells of the infiltrate and some
cells in the osteophyte were negative (yellow arrows).
CD11b expressing cells were present within the sub-
synovial cellular infiltrate 3-days after ACL rupture
(Fig. 2B), with their abundance in the infiltrate increas-
ing by day-14 (Fig. 2D) when they were also detected in
the developing osteophyte (data not shown). Cells
expressing CD11b were also detected in the infiltrate
and developing osteophyte at day-21 (Fig. 2F). Cells
expressing CD11b were present within the inflamma-
tory infiltrate surrounding the ACL/posterior cruciate
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ligament (PCL) complex from day-3 onwards and
within the ACL/PCL at day-14 and -21 (Suppl. Fig. S3).
These expression patterns were not observed in unin-
jured legs as no inflammatory infiltrate or osteophytes
were present (data not shown). In both uninjured and
injured legs, osteoblasts, bone marrow, and megakar-
yocytes expressed F4/80 and cells within the blood
vessels expressed CD11b (Suppl. Fig. S3).
IL-6 and IL-17A Protein Expression Increases in Injured
Knees
Staining for IL-6 and IL-17A was carried out at 3-,
14-, and 21-days post-ACL rupture in sections from
injured (Fig. 3) and uninjured knees (Suppl. Fig. S4).
In uninjured knees, IL-6 was expressed in cells
surrounding the ACL/PCL complex and within the
bone, the growth plates and synovium, and IL-17 in
chondrocytes, osteoblasts, and growth plates. In in-
jured knees, IL-6 expression was abundant within the
matrix of the ACL ligament at all time points
(Fig. 3A–C) whereas IL-17A was not expressed within
the ACL at day-3 (Fig. 3A’) but was at day-14 and   21
(Fig. 3B’ and C’). Within the femoral condyle after
injury, periosteal cells expressed IL-6 but not IL-17A
at day-3 (Fig. 3D and D’) although IL-17A was
expressed in the nearby inflammatory infiltrate
(Fig. 3D’). At day-14 and -21, IL-6 immunolocalized to
matrix and IL-17A intracellularly to regions where
hypertrophic chondrocytes of developing osteophytes
resided (Fig. 3E, E’, F, F’). At day-3 and -14 after
injury, IL-6 expression was abundant within the
matrix surrounding the synovial infiltrate
(Fig. 3G and H) whereas consecutive sections were
negative for IL-17A (Fig. 3G’ and H’). IL-6 was not
detected in the meniscus until day-21 after injury
(Fig. 3I), whereas IL-17A was expressed within the
meniscus at day-14 and -21 (Fig. 3H’ and I’).
Joint Degeneration Occurs Rapidly Following ACL Injury
An acute inflammatory response, in the form of
synovial thickening and increased cellular infiltrate,
was observed at day-3 following ACL rupture
(Fig. 4A). By day-14, new matrix deposition was
observed within injured ACLs along with substantial
medial compartment cartilage loss, bone remodeling,
and osteophyte formation (Fig. 4A). Synovial thicken-
ing and cellular infiltrate remained at day-21 following
ACL injury as well as increased matrix deposition
within the ACL and joint capsule. To assess whether
ACL ligament injury caused joint degeneration, knees
were scored using the OARSI score25 (Fig. 4B). No
significant change was detected with the uninjured,
contralateral legs across the time course and these did
not differ from naive knees (data not shown), therefore
contralateral knees were used for statistical compari-
son. GLM ANOVA of OARSI scores comparing time
versus injury at day-14 revealed significant effects of
time (p< 0.001) and injury (p< 0.001). In the injured
leg at day-14, total OARSI score (sum of all three
parameters and all four quadrants) was increased
5.9-fold compared to uninjured legs (25.63.2 vs.
4.31.3; p<0.001 following log transformation of
data), and 3.4-fold (7.40.2; p¼0.002) and 2.6-fold
(9.81.4; p¼ 0.006) compared with those of the in-
jured leg at days-0 and -3, respectively. At day-21,
total scores were 4.6-fold higher in the injured leg
compared to the uninjured leg (29.82.5 vs. 6.50.6;
p< 0.001) and four-fold and three-fold higher than
those of the injured leg at day-0 (p< 0.001) and day-3
(p<0.001), respectively. There were no significant
changes in the uninjured leg over time. At day-14, the
medial compartment was significantly more damaged
in the injured compared to uninjured leg (p<0.001;
Fig. 4B). In contrast, at day-21, damage within both
Figure 1. Knee joint swelling was measured by digital callipers
and expressed as the difference in size between the uninjured
and injured leg. p< 0.05, p< 0.01, p< 0.001 GLM ANOVA
versus day-0 (A). Coronal sections from uninjured and injured
legs over the 21-day time course were stained with Haematoxylin
and Eosin (B). Cellular infiltrate in the sub-synovial lining is
indicated (arrows). Whole joints were scored for the presence of
sub-synovial inflammation (C). LTP, lateral tibial plateau; LFC,
lateral femoral condyle; m, meniscus.  GLM ANOVA
(p< 0.001).
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the lateral and medial compartments contributed to
the total OARSI score (p<0.001 following ranking of
data; Fig. 4B). The tibial plateau of the injured leg had
a significantly increased OARSI score by day-14
(15.71.7 vs. 2.5 0.1; p¼0.02), which did not signifi-
cantly alter by day-21, whereas the OARSI score only
significantly increased within the femoral condyle at
day-21 (13.5 1.6 vs. 2.5 0.3; p<0.001; Fig. 4C).
Breaking down the OARSI score components revealed
significant OA damage in the injured leg by day-3
(p¼ 0.03), that increased on day-14 (p<0.001) and
day-21 (p<0.001), and proteoglycan loss (p< 0.001)
and subchondral bone changes (p¼ 0.002), which were
significantly increased at day-14, and did not alter
significantly at day-21 (Fig. 3D–F). Osteophytes were
present in both the lateral and medial compartments
in all injured knees from day-14 onwards.
Up-Regulation of Genes Involved in Inflammatory and
Degenerative Responses Following ACL Injury
Femoral condylar cartilage was analyzed for transcrip-
tional changes (Fig. 5). In injured knees, iNOS,
ADAMTS-4, MMP-3, and IL-6 were elevated 19.5-fold
(A), 7.7-fold (B), 10.2-fold (C), and 36-fold (D), respec-
tively at 4-h post-ACL rupture. There was no change
in expression of ADAMTS-5, MMP-9, MMP-13, TNF-a
or IFN-g (data not shown).
DISCUSSION
We have described a non-invasive model of PTOA
whereby a single, 12N load at 1.4 mm/s caused a mid-
substance rupture of the ACL, the most commonly
reported type of ACL tear.30 ACL rupture in humans
can occur through various mechanisms but are most
common in non-contact sports following multi-planar
Figure 2. The localization of F4/80 and CD11b
in consecutive sections taken from injured knees
of mice culled at 3, 14, and 21-days post-ACL
rupture was determined by immunohistochemis-
try. Haematoxylin and Eosin (H&E) stained sec-
tions indicate where magnified images are derived
from. At day-3 (A and B), staining for F4/80 was
very weak whereas CD11b was found in a large
number of cells within the inflammatory infiltrate
(solid arrowheads); some cells remained negative
(white arrowheads). At day-14 (C and D) and -21
(E and G), a limited number of F4/80þ cells were
located within the synovial infiltrate (black
arrows); many cells remained negative (white
arrows). Cells within the developing osteophytes
(E) were also positive. CD11b cells were located
throughout the developing osteophyte (F) and
synovial infiltrate. LTP, lateral tibial plateau,
LFC, lateral femoral condyle; MTP, medial tibial
plateau; MFC, medial femoral condyle, m, menis-
cus. Scale bar¼20 mM.
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loading including anterior tibial shear, knee valgus,
and internal tibial rotation. Our current study used a
single load with a degree of rotational force to load the
ACL to failure without obvious damage to the sur-
rounding joint tissues, thus recapitulating an isolated
ACL rupture injury which accounts for 18–40% of
human cases.31–33 This is in keeping with other non-
invasive mouse models that recapitulate isolated ACL
ruptures.9,24 This non-invasive simple to implement,
highly reproducible model of PTOA displays reliable
and consistent OA pathology (only six animals are
required to show effects with 80% power, p< 0.05).
The known point of injury allows disease progression
to be well defined and offers a potential window of
opportunity for testing early drug intervention in the
absence of surgical or immune induction. It also
facilitates identification of early initiating factors post-
injury and associated biomarkers, which may allow for
stratification of patients to specific therapies in the
future. To date, only a few studies have correlated the
very early molecular, cellular and degenerative
changes that occur within the mouse joint after ACL
Figure 3. Consecutive sections were taken from
injured knees of mice culled at 3, 14, and 21-days
post-ACL rupture and stained for IL-6 and IL-17A
by immunohistochemistry. Haematoxylin and Eo-
sin (H&E) stained sections indicate where magni-
fied images are derived from. Medial compartment
inflammation is shown. Strong staining for IL-6
was observed within the extracellular matrix of
the ACL ligament at day-3 (A), day-14 (B), and
day-21 (C). In contrast, at day-3, no staining for
IL-17A was found within the ligament apart from
surrounding a blood vessel (A’). At day-14 (B’) and
day-21 (C’), IL-17A was detected within the cells
of the ligaments. At day-3 the periosteum of the
femoral condyle (arrows, D) was positive for IL-6
but negative for IL-17A (D’); intracellular staining
in the inflammatory infiltrate nearby was, how-
ever, present (arrowheads D’). At day-14 and -21,
IL-6 was observed within the matrix surrounding
the hypertrophic chondrocytes of the developing
osteophytes (double headed arrow, E and F,
respectively). Intracellular staining for IL-17A
was seen on consecutive sections (E’ and F’,
respectively). At day-3 there was abundant stain-
ing for IL-6 within the matrix surrounding the
synovial infiltrate (G); consecutive sections were
negative for IL-17 (G’). At day-14, IL-6 was still
found within this region (H); IL-17A was absent
but present within the nearby meniscus (H’, ). At
day-21, the matrix surrounding hypertrophic
chondrocytes within the meniscus were positive
for IL-6 (I) and strong staining for IL-17A was
found within these cells (I’). ACL, anterior cruci-
ate ligament. Scale bar¼ 50 mM.
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rupture34 [reviewed in16], with the majority describing
the architectural changes that occur within the mus-
culoskeletal structures.9,10,17,24,35 The current study
provides a timeline of changes in inflammatory media-
tors and details the compartmental degenerative
changes that result from the injury allowing the
potential points of intervention to be unveiled (Fig. 6).
In our model, leg swelling peaked at day-1 and was
accompanied by an acute inflammatory response over
the course of the experiment. Synovial hyperplasia
and inflammatory infiltrate, resulting from the rup-
ture of the ACL, comprised a mixture of cell types that
changed as the disease progressed; Cd11bþ cells were
prominent from day-3 whereas mature, F4/80þ macro-
phages invaded from day-14. F4/80þ macrophages are
closely associated with bone remodeling sites, and
osteophyte formation, and when activated produce
inflammatory cytokines including TNF-a, IL-6, and
IL-1.36,37 By day-14, osteophytes developed within the
medial joint compartment, consistent with other
groups who have shown osteophytes develop within
mouse joints following ACL rupture (17 and reviewed
in18).
IL-6 and IL-17 are critical in the pathogenesis of
inflammatory disease38,39 where IL-6 induces IL-17
production from T-cells.40 After ACL rupture, IL-6 was
upregulated within the joint within 3-days post-injury
and preceded significant increases in Cd11bþ macro-
phages, and increased inflammatory and degradative
scores. This is consistent with elevated IL-6 concen-
trations detected in synovial fluids in humans after
joint injury.19,41–44 IL-17A expression increased at
days-14 to -21 mirroring the abundance of F4/80þ
cells, correlating with OA scores, particularly OA and
subchondral bone components. IL-17 up-regulation
correlates with OA progression, synergises with TNF-
a to increase articular cartilage damage, and is
involved in bone remodeling.45–47
Gene expression analysis revealed that key inflam-
matory mediators (e.g., iNOS, IL-6) and matrix
degrading enzymes (ADAMTS-4, MMP-3) are upregu-
lated as early as 4 h post-injury in the femoral condyle
Figure 4. Toluidine blue stained coronal sec-
tions taken from knees at 3, 14, and 21-days post-
ACL rupture (A). Injured knees are shown in the
top panel and uninjured knees in the bottom
panel. All four quadrants of the knee joint are
indicated: Lateral and medial tibial plateaus
(LTP, MTP, respectively), lateral and medial
femoral condyle (LFC, MFC, respectively). Syno-
vial thickening and increased cellular infiltrate
(arrows), new matrix deposition within ACLs and
collateral ligaments (), significant medial com-
partment cartilage loss (arrowheads), bone remod-
elling (arrows) and osteophyte formation
(arrowheads) are shown. Scale bar¼500 mM. Sec-
tions were scored for degeneration using the
OARSI score (B–F). GLM ANOVA comparing the
effect of time (days), uninjured (U) versus injured
(I), medial versus lateral, femoral condyle vs tibial
plateaus; p<0.05, p< 0.01, p< 0.001. Total
score increased with time (B) and at day-14 and
-21, the medial compartment OARSI score in the
injured leg was significantly different to the unin-
jured leg p< 0.001; in addition, at day-21, the
lateral compartment OARSI score in the injured
leg was significantly different to the uninjured leg
p< 0.001. OARSI scores for the femoral condyle
and tibial plateaus (C) and sub-parameters, oste-
oarthritic changes (D), proteoglycan depletion (E),
and subchondral bone (D). At day-14 and -21, the
tibial compartment OARSI score in the injured leg
was significantly different to the uninjured leg
p< 0.001; at day-21, the femoral compartment
OARSI score in the injured leg was also signifi-
cantly different to the uninjured leg p<0.001.
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cartilage of injured knees. A limitation of the analysis
is that we only analyzed the femoral cartilage and not
the rest of the joint as well as only looking at one time
point. In addition, some calcified cartilage will have
been included at the point of harvest. However, the
data confirms that the response to injury is rapid and
degeneration processes are set in motion very early on;
this may reflect why interventions in patients at a
later date may not be successful in preventing OA
progression. In support of this, OARSI scores revealed
that an increase in mean degeneration score was
apparent by day-3, with a significant increase in the
OA component of the score. Disease progression was
rapid and severe 21-days after ACL rupture with
changes in the medial compartment and tibial plateau
occurring prior to the lateral compartment and femo-
ral condyle. These compartmental changes mimic
those of other PTOA models and may reflect a transfer
of abnormal forces to the medial compartment in the
absence of an intact ACL.48,49 The degeneration occurs
rapidly in our model which may not reflect the 10–12
years it takes for OA progression following injury in
humans. This may be a reflection on the different
biomechanics (bipedal versus quadrupedal) or may be
due to differences in cartilage thickness between
species. Despite this caveat, the model does allow us to
study the stages of disease progression in a well-
defined timeline without the requirement of waiting
decades for the disease to manifest itself in patients
within the laboratory environment.
The use of a non-invasive model of PTOA offers
significant benefits over surgical models, for example,
MNX. In these surgical models there are confounding
inflammatory responses induced by the surgery which
may obscure the pathology and prevent demarcation of
early events and the testing of interventions at this
time. In the current study we used the contralateral,
Figure 5. RNA pooled from the femoral condyles
of nine uninjured and nine injured knees was
analyzed by quantitative PCR to determine the
relative expression of (A) iNOS, (B) ADAMTS-4,
(C) MMP-3, and (D) IL-6. Data are presented as
fold change relative to uninjured knees calculated
using the DDCT method with 18S and b-actin as
housekeeping genes (HKGs).
Figure 6. Timeline of changes that occur in inflammatory
markers over the 21-days post-ACL rupture in our mouse model
of PTOA.
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uninjured knee as our statistical comparator which
some studies suggest may be inappropriate due to
altered loading on this limb following joint injury.22,50
However, we saw no statistically significant changes in
any of the outcome measures in this leg over the course
of the experiment or when compared to na€ve knees and
thus, in line with the 3Rs we used the contralateral limb
as our control. In addition to the limitations described
there are a number of points that should be acknowl-
edged regarding the use of mice as models of OA. Mice
have thin articular cartilage which does not exhibit the
zonal organization of human cartilage. Despite this,
matrix composition is conserved between species.51
Mouse meniscal cartilage is often ossified which limits
the benefit of examining changes that occur in this
tissue; their mechanical role, however, is preserved.
Murine joint biomechanics are very different to bi-pedal
humans and as such could result in divergent loading
patterns and location of degenerative changes; however
mechanical stresses are well conserved across species
including mice.52 In addition, the growth plates of mice
do not close which may affect the bone’s response to
injury and therapeutic intervention; the use of skeletally
mature animals as used in the current study will go
some way to overcoming this issue.
There is no clear consensus why ACL reconstruction
is not an effective intervention to prevent disease
progression; this may be due to irreparable damage
already having occurred due to inflammatory events at
the time of injury. Thus, stratification of treatments may
be better aimed toward the period immediately post-
injury. The model utilized in the current study describes
pathologically distinct phases of the disease increasing
our understanding of the molecular and biochemical
events that occur following joint injury which may
translate into a targeted, therapeutic window.
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